{"canonical":"https://abierto.us/vendors/murty-pharmaceuticals-inc-dnjbtj3xbqm6","key":"DNJBTJ3XBQM6","name":"MURTY PHARMACEUTICALS, INC.","uei":"DNJBTJ3XBQM6","city":"LEXINGTON","state":"KY","awards":8,"obligated":"83535.00","notices_won":7,"top_agency_name":"National Institutes of Health","top_naics":"541715","cage":"3BJ06","parent_name":"MURTY PHARMACEUTICALS, INC.","also_known_as":[],"country":"USA","actions":9,"first_action":"2024-04-29","last_action":"2026-08-25","breakdowns":{"naics":[{"key":"541715","name":null,"awards":6,"obligated":"304455.00"},{"key":"325412","name":null,"awards":2,"obligated":"-220920.00"}],"places":[{"key":"KY","name":null,"awards":5,"obligated":"304455.00"},{"key":"MD","name":null,"awards":1,"obligated":"-220920.00"}],"agencies":[{"key":"7529","name":"National Institutes of Health","awards":8,"obligated":"83535.00"}],"award_types":[{"key":"DELIVERY ORDER","name":null,"awards":6,"obligated":"83535.00"}],"competition":[{"key":"FULL AND OPEN COMPETITION","name":null,"awards":8,"obligated":"83535.00"}],"product_service_codes":[{"key":"AN12","name":null,"awards":7,"obligated":"304455.00"},{"key":"AN11","name":null,"awards":1,"obligated":"-220920.00"}]},"awards_list":[{"award_key":"CONT_AWD_75N95025F00001_7529_75N95021D00024_7529","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N95025F00001_7529_75N95021D00024_7529/","piid":"75N95025F00001","parent_piid":"75N95021D00024","award_type":"DELIVERY ORDER","vendor_key":"DNJBTJ3XBQM6","recipient_name":"MURTY PHARMACEUTICALS, INC.","recipient_uei":"DNJBTJ3XBQM6","recipient_cage":"3BJ06","recipient_city":"LEXINGTON","recipient_state":"KY","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIDA","office_key":"o-75N950","first_action_date":"2025-08-26","last_action_date":"2025-08-26","actions":1,"obligated":"92724.00","current_total_value":"92724.00","potential_total_value":"92724.00","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":null,"offers_received":null,"description":"FY25. TO 6 - DRUG PRODUCT STABILITY STUDIES. POP 9/13/25-9/12/26.","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_75N98026F00001_7529_75N95021D00024_7529","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N98026F00001_7529_75N95021D00024_7529/","piid":"75N98026F00001","parent_piid":"75N95021D00024","award_type":"DELIVERY ORDER","vendor_key":"DNJBTJ3XBQM6","recipient_name":"MURTY PHARMACEUTICALS, INC.","recipient_uei":"DNJBTJ3XBQM6","recipient_cage":"3BJ06","recipient_city":"LEXINGTON","recipient_state":"KY","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH OLAO","office_key":"o-75N980","first_action_date":"2026-08-25","last_action_date":"2026-08-25","actions":1,"obligated":"92724.00","current_total_value":"92724.00","potential_total_value":"92724.00","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":null,"offers_received":null,"description":"FY26. TO 7 - DRUG PRODUCT STABILITY STUDIES. POP 9/13/26-9/12/27.","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_75N95024F00001_7529_75N95021D00024_7529","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N95024F00001_7529_75N95021D00024_7529/","piid":"75N95024F00001","parent_piid":"75N95021D00024","award_type":"DELIVERY ORDER","vendor_key":"DNJBTJ3XBQM6","recipient_name":"MURTY PHARMACEUTICALS, INC.","recipient_uei":"DNJBTJ3XBQM6","recipient_cage":"3BJ06","recipient_city":"LEXINGTON","recipient_state":"KY","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIDA","office_key":"o-75N950","first_action_date":"2024-09-12","last_action_date":"2024-09-12","actions":1,"obligated":"90784.00","current_total_value":"90784.00","potential_total_value":"90784.00","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":null,"offers_received":null,"description":"FY24. TO 5 - DRUG PRODUCT STABILITY STUDIES. POP 9/13/24-9/12/25.","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_75N95021F00001_7529_75N95021D00024_7529","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N95021F00001_7529_75N95021D00024_7529/","piid":"75N95021F00001","parent_piid":"75N95021D00024","award_type":"DELIVERY ORDER","vendor_key":"DNJBTJ3XBQM6","recipient_name":"MURTY PHARMACEUTICALS, INC.","recipient_uei":"DNJBTJ3XBQM6","recipient_cage":"3BJ06","recipient_city":"LEXINGTON","recipient_state":"KY","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIDA","office_key":"o-75N950","first_action_date":"2024-09-10","last_action_date":"2024-09-10","actions":1,"obligated":"28223.00","current_total_value":"312612.00","potential_total_value":"312612.00","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":null,"offers_received":null,"description":"FY21. TO 1 - MANUFACTURE OF CGMP METHAMPHETAMINE HCL FOR IV INJECTION. POP 9/18/21-3/14/25.","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_75N95023F00001_7529_75N95021D00024_7529","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N95023F00001_7529_75N95021D00024_7529/","piid":"75N95023F00001","parent_piid":"75N95021D00024","award_type":"DELIVERY ORDER","vendor_key":"DNJBTJ3XBQM6","recipient_name":"MURTY PHARMACEUTICALS, INC.","recipient_uei":"DNJBTJ3XBQM6","recipient_cage":"3BJ06","recipient_city":"LEXINGTON","recipient_state":"KY","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIDA","office_key":"o-75N950","first_action_date":"2024-08-30","last_action_date":"2024-08-30","actions":1,"obligated":"0","current_total_value":"245582.00","potential_total_value":"245582.00","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":null,"offers_received":null,"description":"MANUFACTURE OF MORPHINE SULFATE PELLETS; TASK ORDER 03, FY23","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_IDV_75N95021D00024_7529","permalink":"https://www.usaspending.gov/award/CONT_IDV_75N95021D00024_7529/","piid":"75N95021D00024","parent_piid":null,"award_type":null,"vendor_key":"DNJBTJ3XBQM6","recipient_name":"MURTY PHARMACEUTICALS, INC.","recipient_uei":"DNJBTJ3XBQM6","recipient_cage":"3BJ06","recipient_city":"LEXINGTON","recipient_state":"KY","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIDA","office_key":"o-75N950","first_action_date":"2024-08-22","last_action_date":"2024-08-22","actions":1,"obligated":"0","current_total_value":null,"potential_total_value":"7000000.00","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":2,"description":"DEVELOPMENT & MANUFACTURE OF PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF SUBSTANCE ABUSE DISORDER. IDIQ. POP 9/18/21-9/17/26","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_IDV_75N95026D00003_7529","permalink":"https://www.usaspending.gov/award/CONT_IDV_75N95026D00003_7529/","piid":"75N95026D00003","parent_piid":null,"award_type":null,"vendor_key":"DNJBTJ3XBQM6","recipient_name":"MURTY PHARMACEUTICALS, INC.","recipient_uei":"DNJBTJ3XBQM6","recipient_cage":"3BJ06","recipient_city":"LEXINGTON","recipient_state":"KY","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIDA","office_key":"o-75N950","first_action_date":"2026-06-24","last_action_date":"2026-06-24","actions":1,"obligated":"0","current_total_value":null,"potential_total_value":"49885703.00","naics":"325412","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":7,"description":"\"EO 14398\"; IDIQ: CHEMISTRY, MANUFACTURING AND CONTROLS AND RELATED SERVICES FOR DEVELOPMENT OF DRUG PRODUCTS (TRND 3)","method":null,"confidence":null,"evidence":null,"opportunity_key":"75N95025R00005","opportunity_title":"Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products"},{"award_key":"CONT_AWD_75N95019F00088_7529_HHSN271201700021I_7529","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N95019F00088_7529_HHSN271201700021I_7529/","piid":"75N95019F00088","parent_piid":"HHSN271201700021I","award_type":"DELIVERY ORDER","vendor_key":"DNJBTJ3XBQM6","recipient_name":"MURTY PHARMACEUTICALS, INC.","recipient_uei":"DNJBTJ3XBQM6","recipient_cage":"3BJ06","recipient_city":"LEXINGTON","recipient_state":"KY","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIDA","office_key":"o-75N950","first_action_date":"2024-04-29","last_action_date":"2024-05-23","actions":2,"obligated":"-220920.00","current_total_value":"145728.00","potential_total_value":"145728.00","naics":"325412","psc":"AN11","extent_competed":"FULL AND OPEN COMPETITION","set_aside":null,"offers_received":3,"description":"DE-OBLIGATE REMAINING FISCAL YEAR 2019 FUNDS.","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":8,"awards_page":1,"won":[{"key":"75N95025R00005","latest_notice_id":"d81e605f738c405282b6af1b4cfd0efc","title":"Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products","solicitation_number":"75N95025R00005","notice_type":"a","first_type":"k","first_posted":"2024-11-30","last_posted":"2026-07-08","notices":7,"due_at":"2025-02-03T20:00:00Z","due_date":"2025-02-03","closes_at":"2025-02-03T20:00:00Z","awardable":false,"open":false,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7529","sub_name":"NATIONAL INSTITUTES OF HEALTH","office_key":"o-75N930","office_name":"NATIONAL INSTITUTES OF HEALTH NIAID","naics":"325412","psc":"AN12","set_aside":null,"state":"MD","county":"24021","county_name":"Frederick County","city":"2430325","city_name":"Frederick","country":"USA","winner":"MURTY PHARMACEUTICALS, INC.","winner_key":"DNJBTJ3XBQM6","amount":"49885703.00","linked_awards":28,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z"}],"won_total":1,"solicitations_won":[{"key":"75N95025R00005","url":"https://abierto.us/opportunities/75n95025r00005","title":"Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products","solicitation_number":"75N95025R00005","notice_type":"a","open":false,"response_deadline":"2025-02-03T20:00:00Z","first_posted":"2024-11-30","last_posted":"2026-07-08","department":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","subagency":"NATIONAL INSTITUTES OF HEALTH","office":"NATIONAL INSTITUTES OF HEALTH NIAID","naics":"325412","psc":"AN12","set_aside":null,"place_state":"MD","place_county":"24021","place_county_name":"Frederick County","place_city":"2430325","place_city_name":"Frederick","winner":"MURTY PHARMACEUTICALS, INC.","award_amount":"49885703.00","publications":7}]}